Study of Minirin Melt® in Adult Patients With Nocturia
NCT03089073 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 835
Last updated 2021-02-05
Summary
Observation of safety and efficacy of Minirin Melt® in adult patients with nocturia
Conditions
- Nocturia
Interventions
- DRUG
-
Desmopressin
60μg or 120μg once daily at bedtime
Sponsors & Collaborators
-
Ferring Pharmaceuticals
lead INDUSTRY
Principal Investigators
-
Global Clinical Compliance · Ferring Pharmaceuticals
Eligibility
- Min Age
- 19 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-13
- Primary Completion
- 2018-10-05
- Completion
- 2018-10-05
Countries
- South Korea
Study Locations
More Related Trials
-
A Study of Minirin Melt in Patients With Nocturia
NCT01212224 ·Status: COMPLETED
-
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects
NCT02904759 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia
NCT01552395 ·Status: COMPLETED
-
MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis
NCT01368913 ·Status: COMPLETED
-
A Study of Minirin Melt in Patients With Nocturia
NCT01222598 ·Status: COMPLETED
-
Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects
NCT03051009 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Men
NCT01694498 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects
NCT02905682 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women
NCT01684800 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients
NCT01262456 ·Status: COMPLETED ·Phase: PHASE3
-
Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women
NCT01729819 ·Status: COMPLETED ·Phase: PHASE2
-
Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study
NCT01435083 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults
NCT03201419 ·Status: COMPLETED ·Phase: PHASE2
-
Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis
NCT01078753 ·Status: COMPLETED ·Phase: PHASE3
-
Desmopressin Response in the Young
NCT00230594 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients
NCT01530451 ·Status: TERMINATED ·Phase: PHASE3
-
Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary
NCT01552343 ·Status: COMPLETED ·Phase: PHASE3
-
Desmopressin in the Treatment of Mixed Nocturia With Nocturnal Polyuria and Low Nocturnal Bladder Capacity
NCT00902655 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis
NCT00245479 ·Status: COMPLETED ·Phase: PHASE4
-
Daytime Impact Sleep Study
NCT01779466 ·Status: TERMINATED ·Phase: PHASE2
-
Prevalence and Risk Factors Nocturnal Polyuria in Female OAB
NCT03810027 ·Status: COMPLETED
-
Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing
NCT03251300 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy Study of Methenamine + Methylthioninium Chloride vs Phenazopyridine for the Symptomatic Control of Dysuria
NCT01657448 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion
NCT02068560 ·Status: COMPLETED ·Phase: NA
-
A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China
NCT03572231 ·Status: COMPLETED